Quadrant Capital Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-231
| Closed | -$57K | – | 2896 |
|
|
2022
Q3 | $57K | Sell |
231
-12
| -5% | -$2.96K | 0.01% | 973 |
|
|
2022
Q2 | $60K | Buy |
243
+47
| +24% | +$11.6K | 0.01% | 816 |
|
|
2022
Q1 | $65K | Buy |
196
+8
| +4% | +$2.65K | 0.01% | 833 |
|
|
2021
Q4 | $68K | Buy |
188
+32
| +21% | +$11.6K | 0.01% | 806 |
|
|
2021
Q3 | $51K | Buy |
156
+5
| +3% | +$1.64K | 0.01% | 858 |
|
|
2021
Q2 | $47K | Sell |
151
-21
| -12% | -$6.54K | 0.01% | 868 |
|
|
2021
Q1 | $55K | Buy |
172
+10
| +6% | +$3.2K | 0.01% | 782 |
|
|
2020
Q4 | $53K | Hold |
162
| – | – | 0.01% | 730 |
|
|
2020
Q3 | $45K | Hold |
162
| – | – | 0.01% | 694 |
|
|
2020
Q2 | $39K | Sell |
162
-19
| -10% | -$4.57K | 0.01% | 813 |
|
|
2020
Q1 | $28K | Sell |
181
-80
| -31% | -$12.4K | ﹤0.01% | 1148 |
|
|
2019
Q4 | $43K | Buy |
261
+135
| +107% | +$22.2K | 0.01% | 1414 |
|
|
2019
Q3 | $20K | Sell |
126
-171
| -58% | -$27.1K | ﹤0.01% | 1597 |
|
|
2019
Q2 | $74K | Buy |
297
+2
| +0.7% | +$498 | 0.01% | 1023 |
|
|
2019
Q1 | $81K | Buy |
295
+170
| +136% | +$46.7K | 0.01% | 929 |
|
|
2018
Q4 | $38K | Hold |
125
| – | – | 0.01% | 984 |
|
|
2018
Q3 | $53K | Hold |
125
| – | – | 0.02% | 633 |
|
|
2018
Q2 | $49K | Hold |
125
| – | – | 0.02% | 663 |
|
|
2018
Q1 | $34K | Hold |
125
| – | – | 0.01% | 759 |
|
|
2017
Q4 | $21K | Hold |
125
| – | – | 0.01% | 906 |
|
|
2017
Q3 | $19K | Buy |
125
+15
| +14% | +$2.28K | 0.01% | 928 |
|
|
2017
Q2 | $13K | Hold |
110
| – | – | 0.01% | 1025 |
|
|
2017
Q1 | $12K | Buy |
110
+23
| +26% | +$2.51K | 0.01% | 1025 |
|
|
2016
Q4 | $9K | Sell |
87
-29
| -25% | -$3K | ﹤0.01% | 1066 |
|
|
2016
Q3 | $13K | Hold |
116
| – | – | 0.01% | 957 |
|
|
2016
Q2 | $11K | Buy |
116
+13
| +13% | +$1.23K | 0.01% | 980 |
|
|
2016
Q1 | $8K | Buy |
+103
| New | +$8K | 0.01% | 1051 |
|